A defining feature of many cancers is genomic instability, which refers to the increased likelihood of acquiring mutations during cell division. These alterations can serve as potential biomarkers for diagnostic, prognostic, predictive, and therapeutic purposes. To identify mutations, such as single nucleotide polymorphisms and copy number variations, scientists use several cytogenetic techniques. 
Genetics & Genomics
Exploring the Impact of Missense Mutations
Thermo Fisher Scientific Inc. (NYSE: TMO) is the world leader in serving science, with annual revenue of approximately $40 billion. Our Mission is to enable our customers to make the world healthier, cleaner and safer. Whether our customers are accelerating life sciences research, solving complex analytical challenges, increasing productivity in their laboratories, improving patient health through diagnostics or the development and manufacture of life-changing therapies, we are here to support them. Our global team delivers an unrivaled combination of innovative technologies, purchasing convenience and pharmaceutical services through our industry-leading brands, including Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab Services, Patheon and PPD.
